Skip to main content
Veterinary Medicines

PARVOSUIN-MR/AD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ

Authorised
  • Erysipelothrix rhusiopathiae, Inactivated
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Aujeszky's disease virus, strain Bartha K61, Live

Product identification

Medicine name:
PARVOSUIN-MR/AD ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ
Active substance:
  • Erysipelothrix rhusiopathiae, Inactivated
  • Porcine parvovirus, strain NADL-2, Inactivated
  • Aujeszky's disease virus, strain Bartha K61, Live
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, Inactivated
    0.28
    gram(s)
    /
    2.00
    millilitre(s)
  • Porcine parvovirus, strain NADL-2, Inactivated
    0.26
    gram(s)
    /
    2.00
    millilitre(s)
  • Aujeszky's disease virus, strain Bartha K61, Live
    0.26
    gram(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 95615/20-10-2021/K-0093201
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 14/06/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 14/06/2023